Total hemoglobin reduction in the tumor volume correlates with response to breast cancer neoadjuvant chemotherapy within two weeks of treatment: ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE AND SURGERY XVI

Mirella Altoe; Alessandro Marone; Hyun Keol Kim; Mariella Tejada; Hanina Hibshoosh; Katherine D. Crew; Kevin Kalinsky; Dawn Hershman; Andreas Hielscher

Total hemoglobin reduction in the tumor volume correlates with response to breast cancer neoadjuvant chemotherapy within two weeks of treatment: ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE AND SURGERY XVI

Mirella Altoe, Alessandro Marone, Hyun Keol Kim, Mariella Tejada, Hanina Hibshoosh, Katherine D. Crew, Kevin Kalinsky, Dawn Hershman, Andreas Hielscher

Biomedical Engineering

Research output: Contribution to conference › Abstract

Original language	English (US)
State	Published - 2019

Cite this

@conference{95e0de3e4f4046c78fe7acf569717561,

title = "Total hemoglobin reduction in the tumor volume correlates with response to breast cancer neoadjuvant chemotherapy within two weeks of treatment: ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE AND SURGERY XVI",

author = "Mirella Altoe and Alessandro Marone and Kim, {Hyun Keol} and Mariella Tejada and Hanina Hibshoosh and Crew, {Katherine D.} and Kevin Kalinsky and Dawn Hershman and Andreas Hielscher",

year = "2019",

language = "English (US)",

}

TY - CONF

T1 - Total hemoglobin reduction in the tumor volume correlates with response to breast cancer neoadjuvant chemotherapy within two weeks of treatment

T2 - ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE AND SURGERY XVI

AU - Altoe, Mirella

AU - Marone, Alessandro

AU - Kim, Hyun Keol

AU - Tejada, Mariella

AU - Hibshoosh, Hanina

AU - Crew, Katherine D.

AU - Kalinsky, Kevin

AU - Hershman, Dawn

AU - Hielscher, Andreas

PY - 2019

Y1 - 2019

M3 - Abstract

ER -